TITLE

CMS Won't Reject Claims Based on PECOS Edits This Month

PUB. DATE
June 2010
SOURCE
Part B Insider;6/26/2010, Vol. 11 Issue 24, pp187
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the implication of the deadline for claim submissions of the services or items at the U.S. Centers for Medicare and Medicaid Services (CMS's) system which is on July 6, 2010. It elaborates the inaccessibility of the Medicare Provider Enrollment, Chain, and Ownership System (PECOS) and the CMS' assurance in not implementing automatic rejection of claims submitted by Medicare providers.
ACCESSION #
52103811

 

Related Articles

  • CMS Demonstrations Target Common Factors Leading to Improper Payment.  // American Family Physician;12/15/2011, Vol. 84 Issue 12, following p1409 

    The article announces the launch of three demonstration programs targeted at minimizing improper payments by the U.S. Centers for Medicare and Medicaid Services (CMS) in December 2011.

  • Medicaid DSH final rule.  // AHA News;9/27/2013, Vol. 49 Issue 19, p3 

    The article reports on the final methodology rule issued by the Centers for Medicare & Medicaid Services (CMS) in September 2013, which establishes separate Disproportionate Share Hospital (DSH) reduction pools for low-DSH states and other states, and the distribution of reductions in each pool.

  • FYI.  // HR Specialist: Compensation & Benefits;May2010, Vol. 5 Issue 5, p8 

    The article reports that the implementation of the new rules that require certain employees to report medical benefits payments has been postponed by the U.S. Centers for Medicare and Medicaid Services (CMS).

  • CMS Delays 5010 Enforcement, Notifies of Missed Claims.  // ACA News (American Chiropractic Association);May2012, Vol. 8 Issue 5, p9 

    No abstract available.

  • Community pharmacy prevails in battle over AMPs.  // Chain Drug Review;4/25/2011, Vol. 33 Issue 8, p44 

    The article reports that the U.S. Centers for Medicare and Medicaid Services has ruled the withdrawal of provisions in the Medicaid pharmacy reimbursement formula under the average manufacturer price (AMP) model.

  • Long AMP battle comes to a close.  // Chain Drug Review;12/6/2010, Vol. 32 Issue 21, p1 

    The article reports on the removal of Medicaid pharmacy reimbursement formula provisions under the average manufacturer price (AMP) model by the U.S. Centers for Medicare & Medicaid Services (CMS).

  • Gov't Pullback Slams Myriad. Investor's Business Daily // Investors Business Daily;12/31/2013, pA01 

    9 The Centers for Medicare and Medicaid Services confirmed over the weekend it would pay $1,438 on some of the company's breast-cancer vulnerability tests on Jan. 1 after previously saying it would pay $2,795. Some analysts said the prior reimbursement rate could have been a clerical error, but...

  • CMS Issues Proposed Rule for Value-Based Purchasing.  // hfm (Healthcare Financial Management);Mar2011, Vol. 65 Issue 3, p11 

    The article reports on the proposed rule given by the Centers for Medicare & Medicaid Services (CMS) for its value-based purchasing (VBO) program in the U.S.

  • Association Between the Medicare Modernization Act of 2003 and Patient Wait Times and Travel Distance for Chemotherapy. Shea, Alisa M.; Curtis, Lesley H.; Hammill, Bradley G.; DiMartino, Lisa D.; Abernethy, Amy P.; Schulman, Kevin A. // JAMA: Journal of the American Medical Association;7/9/2008, Vol. 300 Issue 2, p189 

    The article presents a study comparing patient wait times and travel distances for chemotherapy before and after the enactment of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) which altered reimbursements for outpatients chemotherapy drugs and administration...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics